Outcomes-Based Agreements & Innovative Payer Contracting
Actionable Strategies for Leveraging Real-World Data, Sharing Risk and Aligning Price with Value
As the U.S. healthcare system faces increasing pressure to improve patient access to highly effective, yet costly, therapies, there has been a policy shift toward alternative payment models for healthcare delivery. This movement toward value-based care presents an opportunity for payers and manufacturers to explore innovative contracting for pharmaceuticals/medical devices and demonstrate a commitment to improving clinical and cost outcomes. From performance-based agreements to value-added services, the prospects for life sciences to partner with payers around patient access and affordability are growing.
CBI’s Outcomes-Based Agreements & Innovative Payer Contracting summit delivers key insights into building successful manufacturer-payer partnerships through novel contracting approaches. Join cross-industry stakeholders including payers, PBMs, providers and manufacturers to explore how to navigate the changing regulatory and policy landscape, structure value-based agreements and measure outcomes with real-world data.
